Furthermore, galectin-9 levels were significantly increased in patients with CLL (725.9 ± 221.5) when compared to the control group (53.42 ± 23.55), p < 0.0001. The gene discussed is LGALS9; the disease is B-cell chronic lymphocytic leukemia.